Skip to content
Yog Pharma
6 minute read

What ICH Q7 requires on an API certificate of analysis, what to check line by line, and the warning signs worth a second look.

The certificate of analysis is the one document that travels with every batch of an API. Most are read for a single thing: whether each result sits inside its limit. A CoA says more than that, about the batch and about the source that issued it.

What a CoA has to contain

ICH Q7, the GMP guideline for active pharmaceutical ingredients, sets out the minimum in section 11.4. An authentic certificate of analysis shows:

  • The name of the API, its grade where there is one, the batch number and the date of release
  • The expiry date or the retest date
  • Each test performed, with its acceptance limits and the numerical results obtained
  • The date and signature of authorized personnel in the quality unit
  • The name, address and telephone number of the original manufacturer

The last point matters when material passes through other hands. If a repacker, agent or broker issues a new certificate, Q7 expects it to name the laboratory that did the analysis, refer to the original manufacturer, and have the original batch certificate attached.

Reading it line by line

  1. The manufacturer and the site. The address should match the site named in the DMF and on the GMP certificate. A different address is a different source until someone explains it.
  2. The specification it was tested against. Look for the monograph and its edition, or the specification number and version. An edition several years old deserves a question.
  3. Numbers, not “complies”. Assay, water content, individual impurities and residual solvents should be reported as figures. “Complies” is fine for appearance and for an identity test.
  4. The impurity table. Each specified impurity, the largest unspecified impurity and the total should all appear. Compare them with the limits in your own specification, not only the manufacturer’s.
  5. Residual solvents. The solvents listed should be the ones declared in the route of synthesis, each with a result against its ICH Q3C limit.
  6. The dates. Work out how much of the retest period will be left when the material reaches your warehouse, and when it reaches your production schedule.
  7. The signature. It should come from the quality unit, with a date on or after the last test.

Why three batches tell you more than one

One CoA shows that a batch passed. Three, from different campaigns, show whether the process is under control. Look at assay, total impurities and water content side by side. Wide swings suggest a process that is still being adjusted. Results that match to the last decimal across batches deserve a question too, because real analytical data varies.

Warning signs

  • A certificate on a supplier’s letterhead that does not name the original manufacturer
  • Quantitative tests reported only as “complies” or “conforms”
  • No reference to methods, or to the monograph edition used
  • A retest date that leaves little usable time
  • A site address that differs from the one in the DMF

Your own testing still applies

A good CoA does not replace incoming testing. Under 21 CFR 211.84, a finished-dosage manufacturer must run at least one specific identity test on each lot of a component. It may accept the supplier’s report of analysis for the other tests only after establishing that the supplier’s results are reliable, and confirming it at appropriate intervals. That is why the method of analysis belongs in the qualification file alongside the CoA.

Where Yog Pharma fits

The certificate you receive from us is the manufacturer’s own, for the batch you are buying, with the site named on it. A recent one comes with the first quote, and three recent batches are available during qualification.

Sources

Written by Yog Pharma for buyers and quality teams. It is general information, not regulatory advice; check the current version of each source before you rely on it in a filing.